Extrait

To demonstrate the non-inferiority of the post-vaccination (Day 22) hemagglutination inhibition (HI) geometric mean titers (GMTs) of AGRIFLU over the corresponding GMTs of the comparator vaccine for all three strains, in healthy adults aged 50 years and above. To demonstrate non-inferiority of the percentages of subjects achieving seroconversion in antibody titers at Day 22 in the AGRIFLU group over the corresponding percentages of subjects in the comparator group for all three strains, in healthy adults aged 50 years and above. Safety Objectives To evaluate the safety and tolerability of of AGRIFLU or comparator vaccines in healthy adults aged 50 years and above.

Critère d'inclusion

• Influenza

Liens

• ictrp
• euctr